Although disulfiram is a non-specific ALDH inhibitor, our findings provide support to the assumption that ALDH1A1 overexpression is associated with metabolic resistance and may represent an effective target for sensitizing cancer cells to cisplatin. Here, ALDH1A1 is linked to cancer.